The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2019 | Immunoglobulin receptor signalling pathway in CLL
Stefano Casola
• 1 Oct 2019
Stefano Casola, MD, FIRC Institute of Molecular Oncology, Milan, Italy, elaborates on the role of, and interference with, immunoglobulin receptors in chronic lymphocytic leukemia (CLL), while also discussing the ability to predict resistant tumor cells. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
